ロード中...
Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis
Immunotherapy targeting programmed cell death-1 (PD-1) signaling is becoming the standard of care for advanced gastric cancer. We herein report a patient with gastric adenocarcinoma with peritoneal dissemination who was treated with nab-paclitaxel and ramucirumab following nivolumab and developed sc...
保存先:
| 出版年: | Intern Med |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Japanese Society of Internal Medicine
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543221/ https://ncbi.nlm.nih.gov/pubmed/30626829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.1981-18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|